← SynDRA
LUMEFANTRINE
SynDRA canonical compound SYN0002024 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ATP1A1 |
|---|
| Mechanism of action | antimalarial agent |
|---|
| Indication | malaria |
|---|
| Disease area | infectious disease |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- ATXN2
- CASP3
- CASP7
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- ESR1
- JUN
- KSYK
- NR1I2
- NSD2
- RARA
- SYK
Drug classes
- Antimalarial
- Anti-Infective Agents
- Antimalarials
- Antiparasitic Agents
- Antiprotozoal Agents
- antimalarial agent
ATC classes
Cross-references
Synonyms
- COARTEM
- Coartem
- benflumelol
- benflumetol
- Lumefantrina
- Benflumelol
- Benflumetol
- Dl-benflumelol
- Lumefantrinum
- CPG-56695
- GNF-PF-1971
- Lumefantrine component of coartem
- Dl-Benflumelol
- Lumefantrine (INN)
- Lumefantrine [INN:BAN]
- GNF-Pf-1971
- F38R0JR742
- DTXCID1026663
- CHEBI:156095
- COARTEM COMPONENT LUMEFANTRINE
- RefChem:800121
- dl-Benflumelol
- Lumefantrine, (+)-
- Lumefantrine, (-)-
- C30H32Cl3NO
- D-Benflumelol
- L-Benflumelol
- MFCD05662268
- ZUV4B00D9P
- NCGC00167490-01
- CAS-82186-77-4
- Lumefruntrine
- UNII-F38R0JR742
- Lumefantrine RS
- Lumefantrine [USAN:INN:BAN]
- Lumefantrine (Standard)
- LUMEFANTRINE [MI]
- LUMEFANTRINE [INN]
Reported adverse events
- Abdominal pain
- Arthralgia
- Aspartate aminotransferase increased
- Asthenia
- Chills
- Cough
- Dizziness
- Fatigue
- Headache
- Hepatomegaly
- Hypersensitivity
- Infection
Look up LUMEFANTRINE in the interactive SynDRA portal →